Advertisement

Management of hepatocellular carcinoma in Hong Kong: The Queen Mary Hospital experience

  • Edward C. S. Lai
  • John Wong

Abstract

Primary hepatocellular carcinoma (HCC) is prevalent in various parts of Asia including Hong Kong which has a predominant Chinese population. Even in China, the incidence varies according to the place of birth and permanent residence. In Qi-dong county of Kiangsu province in China, an incidence of 54 per 100,000 has been noted [1]. On the other hand, a high incidence of 1,158 per 100,000 was reported by Beasley and associates in Taipei among male carriers of the hepatitis B surface antigen (HBsAg) [2].

Keywords

Hepatocellular Carcinoma Hepatic Artery Hepatic Resection Primary Liver Cancer Spontaneous Rupture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gibson JB (1983) Primary cancers of the liver. J R Coll Surg Edinb 28: 275–281PubMedGoogle Scholar
  2. 2.
    Beasley RP, Hwang LY, Lin CC, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 2: 1129–1133PubMedCrossRefGoogle Scholar
  3. 3.
    Ong GB, Chan PKW (1976) Primary carcinoma of the liver. Surg Gynecol Obstet 143: 31–38PubMedGoogle Scholar
  4. 4.
    “Hong Kong Annual Department Report 1989-1990” (1990) Ed: Director of Health Services. Government Information Service, Hong Kong, Tables 18, 19Google Scholar
  5. 5.
    Lai CL, Lam KC, Wong KP, Wu PC, Todd D (1981) Clinical features of hepatocellular carcinoma: Review of 211 patients in Hong Kong. Cancer 47: 2746–2755PubMedCrossRefGoogle Scholar
  6. 6.
    Balasegaram M (1972) Complete hepatic dearterialization for primary carcinoma of the liver. Report of twenty-four patients. Am J Surg 124: 340–345PubMedCrossRefGoogle Scholar
  7. 7.
    Almersjo O, Bengmark S, Rudenstam CM, Hafstrom L, Nilsson LAV (1972) Evaluation of hepatic dearterialization in primary and secondary cancer of the liver. Am J Surg 124: 5–9PubMedCrossRefGoogle Scholar
  8. 8.
    Ansfield FJ, Ramirez G, Skibba JL, Bryan GT, Davis HL Jr., Wirtanen GW (1971) Intrahepatic arterial infusion with 5-fluorouracil. Cancer 28: 1147–1151PubMedCrossRefGoogle Scholar
  9. 9.
    Gulesserian HP, Lawton RL, Condon RE (1972) Hepatic artery ligation and cytotoxic infusion in treatment of liver metastases. Arch Surg 105: 280–285PubMedCrossRefGoogle Scholar
  10. 10.
    Fortner JG, Mulcare RJ, Solis A, Watson RC, Golbey RB (1973) Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy. Ann Surg 178: 162–172PubMedCrossRefGoogle Scholar
  11. 11.
    Murray-Lyon IM, Parsons VA, Blendis LM, Dawson JL, Rake MO, Laws JW, Williams R (1970) Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs. Lancet 2: 172–175PubMedCrossRefGoogle Scholar
  12. 12.
    Lai ECS, Choi TK, Tong SW, Ong GB, Wong J (1986) Treatment of unresectable hepatocellular carcinoma: Results of a randomized controlled trial. World J Surg 10: 501–509PubMedCrossRefGoogle Scholar
  13. 13.
    Olweny CL, Toya T, Katongole-Mbidde E, Mugerwa J, Kyalwazi SK, Cohen H (1975) Treatment of hepatocellular carcinoma with Adriamycin. Preliminary communication. Cancer 36: 1250–1257PubMedCrossRefGoogle Scholar
  14. 14.
    Olweny CL, Katongole-Mbidde E, Bahendeka S, Otim D, Mugerwa J, Kyalwazi SK (1980) Further experience in treating patients with hepatocellular carcinoma in Uganda. Cancer 46: 2717–2722PubMedCrossRefGoogle Scholar
  15. 15.
    Johnson PJ, Williams R, Thomas H, Sherlock S, Murray-Lyon IM (1978) Induction of remission in hepatocellular carcinoma with doxorubicin. Lancet 1: 1006–1009PubMedCrossRefGoogle Scholar
  16. 16.
    Vogel CL, Bayley AZ, Brooker RJ, Anthony PP, Ziegler JL (1977) A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States. Cancer 39: 1923–1929PubMedCrossRefGoogle Scholar
  17. 17.
    Falkson G, Moertel CG, Lavin P, Pretorius FJ, Carbone PP (1978) Chemotherapy studies in primary liver cancer: A prospective randomized clinical trial. Cancer 42: 2149–2156PubMedCrossRefGoogle Scholar
  18. 18.
    Lai CL, Wu PC, Chan GCB, Lok ASF, Lin HJ (1988) Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer 62: 479–483PubMedCrossRefGoogle Scholar
  19. 19.
    Choi TK, Lee NW, Wong J (1984) Chemotherapy for advanced hepatocellular carcinoma. Adriamycin versus quadruple chemotherapy. Cancer 53: 401–405PubMedCrossRefGoogle Scholar
  20. 20.
    Tsuruo T (1983) Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics. Cancer Treat Rep 67: 889–894PubMedGoogle Scholar
  21. 21.
    Rogan AM, Hamilton TC, Young RC, Klecker RW Jr, Ozols RF (1984) Reversal of Adriamycin resistance by verapamil in human ovarian cancer. Science 224: 994–996PubMedCrossRefGoogle Scholar
  22. 22.
    Pradhan SG, Basrur VS, Chitnis MP, Adwani SH (1984) In vitro enchancement of Adriamycin cytotoxicity in human myeloid leukemia cells exposed to verapamil. Oncology 41: 406–408PubMedCrossRefGoogle Scholar
  23. 23.
    Reichen J, Hirlinger A, Ha HR, Sagesser S (1986) Chronic verapamil administration lowers portal pressure and improves hepatic function in rats with liver cirrhosis. J Hepatol 3: 49–58PubMedCrossRefGoogle Scholar
  24. 24.
    Kong CW, Lay CS, Tsai YT, Yeh CL, Lai KH, Lee SD, Lo KJ, Chiang BN (1986) The hemodynamic effect ofverapamil on portal hypertension in patients with postnecrotic cirrhosis. Hepatology 6: 423–426PubMedCrossRefGoogle Scholar
  25. 25.
    Lai ECS, Choi TK, Cheng CH, Mok FPT, Fan ST, Tan ESY, Wong J (1990) Doxorubicin for un resectable hepatocellular carcinoma. A prospective study on the addition of verapamil. Cancer 66: 1685–1687PubMedCrossRefGoogle Scholar
  26. 26.
    Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K (1984) Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 95: 586–592PubMedGoogle Scholar
  27. 27.
    Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 7: 462–503PubMedCrossRefGoogle Scholar
  28. 28.
    Lee NW, Wong J, Ong GB (1982) The surgical management of primary carcinoma of the liver. World J Surg 6: 66–75PubMedCrossRefGoogle Scholar
  29. 29.
    Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Chang YC, Niimi K (1986) Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 99: 694–701PubMedGoogle Scholar
  30. 30.
    Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N, Morioka Y (1987) Hepatic resection forhepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg 205: 33–40PubMedCrossRefGoogle Scholar
  31. 31.
    Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, Fujimoto J, Oriyama T, Furukawa K, Kawamura E (1990) Prognostic factors after hepatectomy for hepatocellular carcinoma. A univariate and multivariate analysis. Cancer 65: 1104–1110PubMedCrossRefGoogle Scholar
  32. 32.
    Lee CS, Sung JL, Hwang LY, Sheu JC, Chen DS, Lin TY, Beasley RP (1986) Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma. Surgery 99: 481–490PubMedGoogle Scholar
  33. 33.
    Chen MF, Hwang TL, Jeng LBB, Jan YY, Wang CS, Chou FF (1989) Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg 124: 1025–1028PubMedCrossRefGoogle Scholar
  34. 34.
    Lai ECS, Ng IOL, You KT, Fan ST, Mok FPT, Tan ESY, Wong J (1991) Hepatic resection for small hepatocellular carcinoma: The Queen Mary Hospital experience. World J Surg 15: 654–659PubMedCrossRefGoogle Scholar
  35. 35.
    Tang ZY, Yu YQ, Zhou XD, Ma ZC, Yang R, Lue JZ, Lin ZY, Yang BH (1989) Surgery of small hepatocellular carcinoma. Analysis of 144 cases. Cancer 64: 536–541PubMedCrossRefGoogle Scholar
  36. 36.
    Hsu HC, Wu TT, Wu MZ, Sheu JC, Lee CS, Chen DS (1988) Tumor invasiveness and prognosis in resected hepatocellular carcinoma. Clinical and pathogenetic implications. Cancer 61: 2095–2099PubMedCrossRefGoogle Scholar
  37. 37.
    Iwatsuki S, Gordon RD, Shaw BW Jr, Starzl TE (1985) Role of liver transplantation in cancer therapy. Ann Surg 202: 401–407PubMedCrossRefGoogle Scholar
  38. 38.
    Ong GB, Chu EPH,Yu FYK, Lee TC (1965) Spontaneous rupture of hepatocellular carcinoma. Br J Surg 52: 123–129PubMedCrossRefGoogle Scholar
  39. 39.
    Lai ECS, Wu KM, Choi TK, Fan ST, Wong J (1989) Spontaneous ruptured hepatocellular carcinoma. An appraisal of surgical treatment. Ann Surg 210: 24–28PubMedCrossRefGoogle Scholar
  40. 40.
    Chen MF, Jan YY, Lee TY (1986) Transcatheter hepatic arterial embolization followed by hepatic resection for the spontaneous rupture of hepatocellular carcinoma. Cancer 58: 332–335PubMedCrossRefGoogle Scholar
  41. 41.
    Yeoh EK, Chang WK, Kwan JPW (1984) Epidemiology of viral hepatitis B infection in Hong Kong. In: Lam SK, Lai CL, Yeoh EK (eds) Viral hepatitis B infection in the Western Pacific region: Vaccine and control. World Scientific, Singapore, pp 33–41Google Scholar
  42. 42.
    Hong Kong 1991 (1991) Roberts D (ed). Government Information Services, Hong Kong, p 162Google Scholar

Copyright information

© Springer-Verlag Tokyo 1992

Authors and Affiliations

  • Edward C. S. Lai
    • 1
  • John Wong
    • 1
  1. 1.Department of SurgeryUniversity of Hong Kong, Queen Mary HospitalHong Kong

Personalised recommendations